Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 110

Sort by

Sort Order Select

Journal Articles

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Joshua F Ransom, PhD, Aaron Galaznik, MDMBA, Emelly Rusli, Bruno Lempernesse, MS, Marc Berger, MD

Blood (2019) 134 (Supplement_1): 4895.

https://doi.org/10.1182/blood-2019-129086

Published: 2019

Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 787.

https://doi.org/10.1182/blood-2019-122526

Published: 2019

Journal Articles

Providers Increased the Use of Direct Oral Anticoagulants in Patients with Cancer-Associated Thromboembolism without Gaining Complete Confidence: A Health System-Wide Retrospective Registry Study and a Providers' Survey

Alexander B Pine, MD PhD, Alfred I Lee, MD PhD

Blood (2019) 134 (Supplement_1): 2097.

https://doi.org/10.1182/blood-2019-130200

Published: 2019

Journal Articles

Cancer- Associated Venous Thromboembolism (VTE) Characteristics in Blacks Compared to Whites in Durham County, North Carolina

Ibrahim Saber, MD, Maragatha Kuchibhatla, PhD, Alys Adamski, PhD MPH, Lisa C. Richardson, MDMPH, Nimia Reyes, MD MPH, Karon Abe, PhD, Michele G Beckman, MPH, Elizabeth Thames, Bhavana Singh, MD, Andrea Sitlinger, MD, Ryan Schulteis, Thomas L. Ortel, MD PhD

Blood (2019) 134 (Supplement_1): 3652.

https://doi.org/10.1182/blood-2019-132034

Published: 2019

Journal Articles

Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)

Jeffrey I. Zwicker, MD, David S. Lessen, MD, Philomena Colucci, DO, MS, Dilan Paranagama, PhD, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 168.

https://doi.org/10.1182/blood-2019-123835

Published: 2019

Journal Articles

Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation

Desirée Campoy, MD, Gonzalo Artaza, MD, César A Velasquez, MD, Tania Canals, MD, Erik A Johansson, MD, Katia Flores, MD, Gabriela Bastidas, MD, Silvia Ruiz, MD, Gabriela S Ene, MD PhD, Alessandra Comai, MD, Maricel Subira, MD PhD, Ramón Salinas, MD PhD, Jorge Sierra, MD, Pável E Olivera, MD

Blood (2019) 134 (Supplement_1): 1162.

https://doi.org/10.1182/blood-2019-125150

Published: 2019

Journal Articles

Chimeric Antigen Receptor T Cell Therapy Pipeline at a Glance: A Retrospective and Systematic Analysis from Clinicaltrials.Gov

Eider F Moreno Cortes, MD, Caleb K Stein, PhD, Paula A Lengerke Diaz, MD, Cesar A Ramirez-Segura, BS, PhD, Januario E. Castro, MD

Blood (2019) 134 (Supplement_1): 5629.

https://doi.org/10.1182/blood-2019-132273

Published: 2019

Journal Articles

Clinical Outcomes of Ruxolitinib in the Salvage Treatment of Chronic Graft-Versus-Host Disease

Yanping Ji, Baolin Tang, Xiaoyu Zhu, Huilan Liu, Kaidi Song, Xiang Wan, Wen Yao, Guangyu Sun, Jian Wang, Zimin Sun

Blood (2019) 134 (Supplement_1): 5677.

https://doi.org/10.1182/blood-2019-130138

Published: 2019

Journal Articles

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Faouzi Djebbari, Fotios Panitsas, Catherine Prodger, Fearn Davies, Kieran Burton, Akhil Khera, Grant Vallance, B.Sc., PhD, Sally Moore, Jaimal Kothari, Andy Peniket, MD, Karthik Ramasamy, MD PhD

Blood (2019) 134 (Supplement_1): 4768.

https://doi.org/10.1182/blood-2019-128139

Published: 2019

Journal Articles

Therapeutic Plasma Exchange Practices in Immune Thrombocytopenic Purpura Related Hospitalizations: Real World Practices for a Category III Apheresis Indication

Sarah Makhani, BA, Joseph Schwartz, MD MPH, Aaron Tobian, MD PhD, Saurav Chopra, Ljiljana V. Vasovic, MD, Robert Andrew Desimone, MD, Patricia Shi, MD, Shipra Kaicker, MD, Cassandra D Josephson, MD, James B. Bussel, MD, Ruchika Goel, MD MPH

Blood (2018) 132 (Supplement 1): 3757.

https://doi.org/10.1182/blood-2018-99-111425

Published: 2018

Journal Articles

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease

Gerald A. Soff, MD, Debra M. M Sarasohn, MD, Eva S Haegler-Laube, MD, Sean M Devlin, PhD, Yimei Miao, BS, Gemma Bendheim, BA, Jeanette Batista, RN, Jonathan Wills, Jodi V Mones, MD, Cy Wilkins, MD, Simon H Mantha, MD MPH

Blood (2018) 132 (Supplement 1): 2536.

https://doi.org/10.1182/blood-2018-99-115506

Published: 2018

Journal Articles

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Jordan K. Schaefer, MD, Zhenke Wu, PhD, Mengbing Li, Jennifer J Griggs, MD MPH, Suman L. Sood, MD

Blood (2018) 132 (Supplement 1): 2225.

https://doi.org/10.1182/blood-2018-99-117931

Published: 2018

Journal Articles

Amelioration of Rigosertib Treatment Related Genitourinary (GU) Adverse Events (AEs) in Patients with Myelodysplastic Syndromes: Implementation of Novel Dosing Regimen Derived through Pharmacokinetic Modeling in Phase 2 Study of Oral Rigosertib in Combination with Azacitidine

David Taft, PhD, Tarang Vora, MS, Chen Ren, PhD, Patrick S. Zbyszewski, MBA, Joseph Morgan, MD, Michael E. Petrone, MD MPH, Steven M. Fruchtman, MD, Manoj Maniar, PhD

Blood (2018) 132 (Supplement 1): 4379.

https://doi.org/10.1182/blood-2018-99-118463

Published: 2018

Journal Articles

Health-Related Quality of Life in Waldenstrom Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undeterminated Significance (IgM-MGUS)

Anna Maria Frustaci, Michele Nichelatti, PhD, Marina Deodato, MD, Maddalena Mazzucchelli, MD, Marco Montillo, MD, Roberto Cairoli, Alessandra Tedeschi, MD

Blood (2018) 132 (Supplement 1): 3593.

https://doi.org/10.1182/blood-2018-99-111444

Published: 2018

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

A Twenty Years Epidemiology Study of 2 nd Hematological Malignancies Post to the Initial Tumor Treatment: Report from Southern China Single Cancer Group

Siliang Chen, Zheyuan Qin, Stephen Liang, MD

Blood (2018) 132 (Supplement 1): 5903.

https://doi.org/10.1182/blood-2018-99-118481

Published: 2018

Journal Articles

Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety Results in HMA Treatment Naïve & Relapsed (Rel)/Refractory (Ref) Patients

Shyamala C. Navada, MD, Guillermo Garcia-Manero, MD, Ehab L. Atallah, MD, M. Nabeel Rajeh, MD, Jamile M. Shammo, MD, Elizabeth A. Griffiths, MD, Samer K. Khaled, MD, Shaker R. Dakhil, MD, David E. Young, MD, Rosalie Odchimar-Reissig, RN, Naveen Pemmaraju, MD, Yesid Alvarado, MD, Maro N. Ohanian, DO, Rosmy B. John, MSN, Patrick S. Zbyszewski, MBA, Manoj Maniar, PhD, Michael E. Petrone, MD MPH, Steven M. Fruchtman, MD, Lewis R. Silverman, MD

Blood (2018) 132 (Supplement 1): 230.

https://doi.org/10.1182/blood-2018-99-119259

Published: 2018

Journal Articles

Evaluation of Underlying Cause of Genitourinary (GU) Adverse Events (AEs) in Patients with Myelodysplastic Syndromes upon Oral Administration of Rigosertib: Safety and Pharmacokinetic Analysis of Rigosertib across Three Clinical Trials

Manoj Maniar, PhD, Chen Ren, PhD, Patrick S. Zbyszewski, MBA, Michael E. Petrone, MD MPH, Steven M. Fruchtman, MD, David Taft, PhD

Blood (2018) 132 (Supplement 1): 3106.

https://doi.org/10.1182/blood-2018-99-116982

Published: 2018

Journal Articles

Systematic Review of Infectious Events in Prospective Trials of Ibrutinib

Benjamin Tillman, MD, James Michael Pauff, MD PhD, Gowri Satyanarayana, MD, Mahsa Sharifi Talbott, PharmD, Jeremy Warner, MD MS

Blood (2017) 130 (Supplement 1): 3460.

https://doi.org/10.1182/blood.V130.Suppl_1.3460.3460

Published: 2017

Journal Articles

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

Girish Kunapareddy, MD, Benjamin Switzer, DO, MHSA, MS, Madison Conces, MD, Pramod Pinnamaneni, MD, Bhumika J. Patel, MD, Sagar S. Patel, MD, Alicia Redden, Dana E. Angelini, MD, Keith McCrae, MD, Brad Pohlman, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 3361.

https://doi.org/10.1182/blood.V130.Suppl_1.3361.3361

Published: 2017

NARROW

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Providers Increased the Use of Direct Oral Anticoagulants in Patients with Cancer-Associated Thromboembolism without Gaining Complete Confidence: A Health System-Wide Retrospective Registry Study and a Providers' Survey

Cancer- Associated Venous Thromboembolism (VTE) Characteristics in Blacks Compared to Whites in Durham County, North Carolina

Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)

Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation

Chimeric Antigen Receptor T Cell Therapy Pipeline at a Glance: A Retrospective and Systematic Analysis from Clinicaltrials.Gov

Clinical Outcomes of Ruxolitinib in the Salvage Treatment of Chronic Graft-Versus-Host Disease

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Therapeutic Plasma Exchange Practices in Immune Thrombocytopenic Purpura Related Hospitalizations: Real World Practices for a Category III Apheresis Indication

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Amelioration of Rigosertib Treatment Related Genitourinary (GU) Adverse Events (AEs) in Patients with Myelodysplastic Syndromes: Implementation of Novel Dosing Regimen Derived through Pharmacokinetic Modeling in Phase 2 Study of Oral Rigosertib in Combination with Azacitidine

Health-Related Quality of Life in Waldenstrom Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undeterminated Significance (IgM-MGUS)

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

A Twenty Years Epidemiology Study of 2 nd Hematological Malignancies Post to the Initial Tumor Treatment: Report from Southern China Single Cancer Group

Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety Results in HMA Treatment Naïve & Relapsed (Rel)/Refractory (Ref) Patients

Evaluation of Underlying Cause of Genitourinary (GU) Adverse Events (AEs) in Patients with Myelodysplastic Syndromes upon Oral Administration of Rigosertib: Safety and Pharmacokinetic Analysis of Rigosertib across Three Clinical Trials

Systematic Review of Infectious Events in Prospective Trials of Ibrutinib

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only